Rullán, John VHerrera Guibert, DionisioCano-Portero, RosaMoreno, VictoriaGodoy, PerePeiró, Enrique FCastell, JuanIbañez, ConsueloOrtega, ArturoSánchez Agudo, LeopoldoPozo, Francisco2020-05-052020-05-051996-04Emerg Infect Dis. 1996 Apr-Jun;2(2):125-9.1080-6040http://hdl.handle.net/20.500.12105/9878Before 1990, outbreaks of multidrug-resistanttuberculosis (MDRTB) were uncommon (1); sincethen, more than 10 outbreaks have been reported,all in hospitals and prisons in the eastern UnitedStates (2-7). Persons traditionally considered atrisk for MDRTB (foreign-born TB patients andthose inadequately treated for TB) have not beenassociated with these outbreaks. Instead, the pres-ence of patients with active TB near immunocom-promised patients in HIV-dedicated wards has ledto MDRTB-infected HIV patients whose TB casesoften go unrecognized. The patients receive inade-quate treatment in facilities without effective pro-cedures for isolating acid-fast bacilli; thesecircumstances favor nosocomial transmission.Health officials in other geographic areas whereHIV and TB are major public health threats havebeen alerted to this emerging problem, and sur-veillance systems have been designed (8).engVoRAIDS-Related Opportunistic InfectionsAdultDNA, BacterialFemaleHumansInfectious Disease Transmission, Patient-to-ProfessionalIsoniazidMaleMycobacterium tuberculosisRifampinSpainTuberculosisCross InfectionDrug Resistance, MicrobialDrug Resistance, MultipleAtribución-NoComercial-CompartirIgual 4.0 Internacional890321322125-910.3201/eid0202.960208Emerging infectious diseasesopen access